Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
50%
Ph early_phase_1
1
50%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Early Phase 1First-in-human
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

2

all time

Status Distribution
Completed(2)

Detailed Status

Completed2

Development Timeline

Analytics

Development Status

Total Trials
2
Active
0
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (50.0%)
N/A1 (50.0%)

Trials by Status

completed2100%

Recent Activity

0 active trials
Showing 2 of 2
completednot_applicable

Nicotine Influence on the Retina Following the Use of Electronic Cigarette

NCT05801419
completedearly_phase_1

Vaporized Nicotine and Autonomic Control

NCT04613609

Clinical Trials (2)

Showing 2 of 2 trials
NCT05801419Not Applicable

Nicotine Influence on the Retina Following the Use of Electronic Cigarette

Completed
NCT04613609Early Phase 1

Vaporized Nicotine and Autonomic Control

Completed

All 2 trials loaded

Drug Details

Intervention Type
COMBINATION PRODUCT
Total Trials
2